478 results
Page 3 of 24
11-K
EX-23.1
544u44kr
29 Jun 22
Annual report of employee stock purchases
11:46am
6-K
EX-99.3
f15ky
28 Jun 22
Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vaccine
3:59pm
6-K
EX-99.1
mu2pz14si 020v3r
16 May 22
IFRS net sales reported
1:45pm
6-K
EX-99.1
qq2 yk6szokx72o93wiw
28 Apr 22
Sanofi continues to deliver strong business EPS(1) growth driven by higher sales and improved margins in Q1
12:16pm
6-K
EX-99.3
g68mspx
7 Apr 22
If approved, Dupixent would be the first medicine available in the U.S. indicated to treat eosinophilic esophagitis
3:13pm
6-K
EX-99.1
ljnw9avhr12nl3ntbb
4 Apr 22
Distribution of Shares of Euroapi
11:21am
6-K
EX-99.4
d4qnwac2ysgphologt
30 Mar 22
Late-breaking Phase 3 data at AAD 2022 show Dupixent® (dupilumab) significantly improved signs and symptoms of prurigo nodularis
1:44pm
6-K
EX-99.2
rauyj6qg03d o0
22 Mar 22
Sanofi and Seagen Announce Collaboration to Develop and Commercialize Multiple Novel Antibody-Drug Conjugates
2:29pm
6-K
EX-99.3
rsxgj9 g9atyl
24 Feb 22
Update on ongoing Dupixent® (dupilumab) chronic spontaneous urticaria Phase 3 program
5:14pm
6-K
EX-99.2
eutwpz8w4uu1ta
14 Feb 22
FDA approves Enjaymo™ (sutimlimab-jome), first treatment for use in patients with cold agglutinin disease
2:07pm
6-K
EX-99.1
kftoezaxvy5 4i
4 Feb 22
Strong 2021 sales and business EPS(1) growth enabling increased investment in R&D
9:56am
6-K
EX-99.1
59w3nl2y5s
22 Nov 21
Current report (foreign)
12:42pm
6-K
EX-99.1
1hzxli
9 Nov 21
Sanofi completes acquisition of Kadmon
4:53pm
6-K
EX-99.1
gtckxzqpcyoraqt2ml
28 Oct 21
Q3 2021 sales grew double digit to €10.4 billion (up 10.1%) due to strong growth from Dupixent®, Vaccines and CHC
11:19am
6-K
EX-99.1
5iprpjfz0dyfu
14 Sep 21
Sanofi completes acquisition of Translate Bio, accelerating the application of mRNA in new vaccines and therapeutics
9:38am
6-K
EX-99.1
zi5lv se3
8 Sep 21
Sanofi to acquire Kadmon to further strengthen growth of transplant business
8:01am
SC TO-T
EX-99
8sejaqhh4gte cy
16 Aug 21
Third party tender offer statement
8:09am
SC TO-T
EX-99
v8jtyu7xo68 glhpd
16 Aug 21
Third party tender offer statement
8:09am